Advertisement
Singapore markets close in 7 hours 42 minutes
  • Straits Times Index

    3,165.64
    +10.95 (+0.35%)
     
  • Nikkei

    37,807.15
    -154.65 (-0.41%)
     
  • Hang Seng

    16,251.84
    0.00 (0.00%)
     
  • FTSE 100

    7,847.99
    +27.63 (+0.35%)
     
  • Bitcoin USD

    61,446.57
    -2,259.26 (-3.55%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • Dow

    37,753.31
    -45.66 (-0.12%)
     
  • Nasdaq

    15,683.37
    -181.88 (-1.15%)
     
  • Gold

    2,385.60
    -2.80 (-0.12%)
     
  • Crude Oil

    82.61
    -0.08 (-0.10%)
     
  • 10-Yr Bond

    4.5850
    -0.0740 (-1.59%)
     
  • FTSE Bursa Malaysia

    1,540.04
    -0.38 (-0.02%)
     
  • Jakarta Composite Index

    7,130.84
    -7,164.81 (-50.12%)
     
  • PSE Index

    6,450.04
    +45.07 (+0.70%)
     

If You Invested $10,000 in Regeneron Pharmaceuticals 5 Years Ago, This Is How Much You Would Have Today

If You Invested $10,000 in Regeneron Pharmaceuticals 5 Years Ago, This Is How Much You Would Have Today

Regeneron Pharmaceuticals (NASDAQ: REGN) has been a reliable, steadily growing stock over the years, with the top line and profits increasing. Below, I'll look at just how well the stock has performed over the past five years and whether Regeneron is a good buy moving forward. In early August 2017, shares of Regeneron were trading at around $470 per share.